Influence of infection route and virulence factors on colonization of solid tumors by Salmonella enterica serovar Typhimurium.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  FEMS Immunology & Medical Microbiology

• Publication date

  2011-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1574-695X.2011.00790.xPMID 21314734
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium

  2010cited by this paper
• Salmonella—allies in the fight against cancer

  2010cited by this paper
• Enterobacterial tumor colonization in mice depends on bacterial metabolism and macrophages but is independent of chemotaxis and motility.

  2010cited by this paper
• The arrangement of subspaces in the orthogonal spaces and tighter analysis of an error-tolerant pooling design

  2010cited by this paper
• Survivin minigene DNA vaccination is effective against neuroblastoma

  2009cited by this paper
• Tumor Invasion of Salmonella enterica Serovar Typhimurium Is Accompanied by Strong Hemorrhage Promoted by TNF-α

  2009cited by this paper
• Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium

  2009cited by this paper
• The Salmonella PmrAB regulon: lipopolysaccharide modifications, antimicrobial peptide resistance and more.

  2008cited by this paper
• Salmonella type III-mediated heterologous antigen delivery: a versatile oral vaccination strategy to induce cellular immunity against infectious agents and tumors.

  2008cited by this paper
• Containment of tumor-colonizing bacteria by host neutrophils.

  2008cited by this paper
• Coordinate Regulation of Salmonella Pathogenicity Island 1 (SPI1) and SPI4 in Salmonella enterica Serovar Typhimurium

  2007cited by this paper
• Salmonella typhimurium lacking ribose chemoreceptors localize in tumor quiescence and induce apoptosis.

  2007cited by this paper
• Remote control of tumour‐targeted Salmonella enterica serovar Typhimurium by the use of l‐arabinose as inducer of bacterial gene expression in vivo

  2007cited by this paper
• The Salmonella pathogenicity island 1 and Salmonella pathogenicity island 2 type III secretion systems play a major role in pathogenesis of systemic disease and gastrointestinal tract colonization of Salmonella enterica serovar Typhimurium in the chicken

  2007cited by this paper
• Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice.

  2006cited by this paper
• Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro

  2006cited by this paper
• Molecular interactions between dendritic cells and Salmonella: escape from adaptive immunity and implications on pathogenesis.

  2005cited by this paper
• Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium.

  2005cited by this paper
• The Salmonella Pathogenicity Island (SPI)-2 and SPI-1 Type III Secretion Systems Allow Salmonella Serovar typhimurium to Trigger Colitis via MyD88-Dependent and MyD88-Independent Mechanisms1

  2005cited by this paper
• Cancer immunotherapy based on killing of Salmonella-infected tumor cells.

  2005cited by this paper
• Streptomycin-Pretreated Mice Serovar Typhimurium Colitis in Salmonella enterica Efficient Induction of Flagella and Chemotaxis Are Required for

  2004cited by this paper
• Functions and effectors of the Salmonella pathogenicity island 2 type III secretion system

  2003cited by this paper
• Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors.

  2003cited by this paper
• Pretreatment of Mice with Streptomycin Provides a Salmonella enterica Serovar Typhimurium Colitis Model That Allows Analysis of Both Pathogen and Host

  2003cited by this paper
• Antitumor Effects in Mice of the Intravenous Injection of Attenuated Salmonella Typhimurium

  2002cited by this paper
• Salmonella pathogenicity island-2 and anticancer activity in mice

  2002cited by this paper
• Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma.

  2002cited by this paper
• One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.

  2000cited by this paper
• Salmonella interactions with host cells: in vitro to in vivo.

  2000cited by this paper
• Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium.

  2000cited by this paper
• Salmonella vaccine carrier strains: effective delivery system to trigger anti‐tumor immunity by oral route

  1999cited by this paper
• Macrophage‐dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival

  1998cited by this paper
• Tumor-targeted Salmonella as a novel anticancer vector.

  1997cited by this paper
• Invasion by Salmonella typhimurium is affected by the direction of flagellar rotation

  1992cited by this paper
• The Classic: The Treatment of Malignant Tumors by Repeated Inoculations of Erysipelas

  1991cited by this paper
• Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines

  1981cited by this paper
• Experimental Salmonella typhimurium infection in calves.

  1978cited by this paper

• ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL-15/IL-15Rα and STING payloads to engage innate and adaptive immunity in the TME and enable a durable anti-tumor immune response

  2025cites this paper
• Engineering bacteria for enhanced tumor therapy: from surface modification to synthetic genetic circuits

  2025cites this paper
• Paving the way for bacteria-based drug delivery: biohybrid microrobots emerging from microrobotics and synthetic biology.

  2025cites this paper
• Bacterial derivatives mediated drug delivery in cancer therapy: a new generation strategy

  2024cites this paper
• Towards Understanding Tumour Colonisation by Probiotic Bacterium E. coli Nissle 1917

  2024cites this paper
• Evaluation of tumor-colonizing Salmonella strains using the chick chorioallantoic membrane model

  2024cites this paper
• Bactofection, Bacterial-Mediated Vaccination, and Cancer Therapy: Current Applications and Future Perspectives

  2024cites this paper
• Targeted modulation of gut and intra-tumor microbiota to improve the quality of immune checkpoint inhibitor responses.

  2024cites this paper
• Enhanced bacterial cancer therapy delivering therapeutic RNA interference of c-Myc

  2024cites this paper
• Bioinspired microrobots: Opportunities and challenges in targeted cancer therapy.

  2023cites this paper
• Coating bacteria for anti-tumor therapy

  2022cites this paper
• L-asparaginase mediated therapy in L-asparagine auxotrophic cancers: A review.

  2022cites this paper
• Pattern of F-18 FDG Uptake in Colon Cancer after Bacterial Cancer Therapy Using Engineered Salmonella Typhimurium: A Preliminary In Vivo Study

  2022cites this paper
• Recombinant Attenuated Salmonella enterica as a Delivery System of Heterologous Molecules in Cancer Therapy

  2022influential citation
• Bacterial cancer therapy in autochthonous colorectal cancer affects tumor growth and metabolic landscape

  2021cites this paper
• Bacterial-based cancer therapy: An emerging toolbox for targeted drug/gene delivery.

  2021cites this paper
• Monocytes mediate Salmonella Typhimurium‐induced tumor growth inhibition in a mouse melanoma model

  2021cites this paper
• Phenotypic characterization of auxotrophic mutant of nontyphoidal Salmonella and determination of its cytotoxicity, tumor inhibiting cytokine gene expression in cell line models

  2021cites this paper
• Theranostic Approaches Using Live Bacteria

  2021cites this paper
• Engineering microrobots for targeted cancer therapies from a medical perspective

  2020cites this paper
• Targeted cancer immunotherapy with genetically engineered oncolytic Salmonella typhimurium.

  2020cites this paper
• New technologies in developing recombinant‐attenuated bacteria for cancer therapy

  2020cites this paper
• Monocytes mediate Salmonella Typhimurium-induced tumour growth inhibition

  2020cites this paper
• Engineering the gut microbiota to treat chronic diseases

  2020cites this paper
• Salmonella Typhimurium as a potential anticancer agent: A Review

  2020cites this paper
• Genetically engineered Salmonella Typhimurium: Recent advances in cancer therapy.

  2019cites this paper
• Bacterial Targeting of Tumors

  2019cites this paper
• Attenuated Salmonella typhimurium cancer therapy has direct effects on the tumor epithelium in colorectal cancer

  2019cites this paper
• Nontyphoidal Salmonella: a potential anticancer agent

  2019cites this paper
• Salmonella Typhimurium as an Anticancer Therapy: Recent Advances and Perspectives

  2019cites this paper
• Targeted inactivation of Salmonella Agona metabolic genes by group II introns and in vivo assessment of pathogenicity and anti-tumour activity in mouse model

  2019cites this paper
• Endostatin gene therapy delivered by attenuated Salmonellatyphimurium in murine tumor models

  2018cites this paper
• Cell mass-dependent expression of an anticancer protein drug by tumor-targeted Salmonella

  2018cites this paper
• Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated Salmonella enterica

  2018cites this paper
• Infection by Salmonella enterica Promotes or Demotes Tumor Development

  2018cites this paper
• Bacterial type III secretion system as a protein delivery tool for a broad range of biomedical applications.

  2018cites this paper
• Draft Genome Sequence of the Tumor-Targeting Salmonella enterica Serovar Typhimurium Strain SL 7207

  2017cites this paper
• Optimizing the restored chemotactic behavior of anticancer agent Salmonella enterica serovar Typhimurium VNP20009.

  2017cites this paper
• Effect of Salmonella enterica serovar Typhimurium VNP20009 and VNP20009 with restored chemotaxis on 4T1 mouse mammary carcinoma progression

  2017cites this paper
• Therapeutic benefit of Salmonella attributed to LPS and TNF-α is exhaustible and dictated by tumor susceptibility

  2017cites this paper
• Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy

  2017cites this paper
• Local application of bacteria improves safety of Salmonella-mediated tumor therapy and retains advantages of systemic infection

  2017cites this paper
• Draft Genome Sequence of the Tumor-Targeting Salmonella enterica Serovar Typhimurium Strain SL7207

  2017cites this paper
• Salmonella-Mediated Cancer Therapy: Roles and Potential

  2017cites this paper
• Therapeutic Potential of Bacteria against Solid Tumors.

  2017cites this paper
• Antimelanoma effect of Salmonella Typhimurium integration host factor mutant in murine model.

  2016cites this paper
• Bacteria in Cancer Therapy: Renaissance of an Old Concept

  2016cites this paper
• aroA-Deficient Salmonella enterica Serovar Typhimurium Is More Than a Metabolically Attenuated Mutant

  2016cites this paper
• A phase I clinical study to evaluate safety of orally administered, genetically engineered Salmonella enterica serovar Typhimurium for canine osteosarcoma

  2016cites this paper
• Therapy of solid tumors using probiotic Symbioflor-2 – restraints and potential

  2016cites this paper
• Bioengineered and biohybrid bacteria-based systems for drug delivery.

  2016cites this paper
• The genes slyA, STM3120 and htrA are required for the anticancer ability of VNP20009

  2016cites this paper
• Induction of CD4+ and CD8+ anti‐tumor effector T cell responses by bacteria mediated tumor therapy

  2015cites this paper
• Efficiency of Conditionally Attenuated Salmonella enterica Serovar Typhimurium in Bacterium-Mediated Tumor Therapy

  2015cites this paper
• In Vivo Efficacy of Antimicrobials against Biofilm-Producing Pseudomonas aeruginosa

  2015cites this paper
• Bacterial Cancer Therapy: How Patients Might Benefit from Salmonella Infections

  2015cites this paper
• Rescuing chemotaxis of the anticancer agent Salmonella enterica serovar Typhimurium VNP20009.

  2015cites this paper
• [Salmonella enterica: an ally in the therapy of cancer].

  2015cites this paper
• Salmonella enterica: un aliado en la terapia contra el cáncer

  2015cites this paper
• Lipid A controls the robustness of intratumoral accumulation of attenuated Salmonella in mice

  2014influential citation
• Murine solid tumours as a novel model to study bacterial biofilm formation in vivo

  2014cites this paper
• Improved cytotoxic effects of Salmonella-producing cytosine deaminase in tumour cells

  2014cites this paper
• Bacteria-Enabled Autonomous Drug Delivery Systems: Design, Modeling, and Characterization of Transport and Sensing

  2014cites this paper
• Efficient tumor targeting by anaerobic butyrate-producing bacteria.

  2013cites this paper
• Motility is critical for effective distribution and accumulation of bacteria in tumor tissue.

  2012cites this paper
• The preclinical discovery of bacterial therapy for the treatment of metastatic cancer with unique advantages

  2012cites this paper
• Ilhas de patogenicidade de Salmonella enterica: uma revisão Salmonella enterica pathogenicity islands: a review

  2012cites this paper
• Antibiotic control of tumor-colonizing Salmonella enterica serovar Typhimurium

  2011cites this paper